<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6466164\results\search\disease\results.xml">
  <result pre="viruses mouse models knockout mice transgenic mice humanized mice HIV" exact="influenza" post="dengue 1. Introduction Infectious diseases caused by human pathogenic"/>
  <result pre="(HIV) infections [1]. More than 90 million new cases of" exact="influenza" post="occur every year in children aged less than five"/>
  <result pre="transgenic mice include mice expressing a transgenic TCR specific to" exact="influenza" post="virus hemagglutinin (HA) in the context of the major"/>
  <result pre="activation of CD8+T cells [4,5]. Furthermore, many human viruses like" exact="hepatitis" post="viruses, polioviruses, papillomaviruses, HIV, and measles are not infectious"/>
  <result pre="many human viruses like hepatitis viruses, polioviruses, papillomaviruses, HIV, and" exact="measles" post="are not infectious to wild-type mice, but the transgenic"/>
  <result pre="advantages and restrictions; hence, selecting an appropriate model for a" exact="viral disease" post="of interest is of paramount importance. Schematic representation of"/>
  <result pre="the most significant inventions in modern medicine, providing effective virus" exact="suppression" post="and radically enhancing the quality of life and life"/>
  <result pre="mice [33]; 3′ half of the HIV genome, causing severe" exact="nephropathy" post="[34]; and expression of HIV-1 Tat or Nef proteins,"/>
  <result pre="Influenza A pandemics have caused considerable disease and deaths. While" exact="influenza" post="A and B cause only acute febrile illness in"/>
  <result pre="[64]. Influenza infections may promote and intensify numerous conditions like" exact="chronic obstructive pulmonary disease" post="(COPD) [65] and, asthma [66]; They can increase the"/>
  <result pre="numerous conditions like chronic obstructive pulmonary disease (COPD) [65] and," exact="asthma" post="[66]; They can increase the risk of a cerebro-vascular"/>
  <result pre="women [68]. Though antiviral therapies, drugs, and vaccines are available," exact="influenza" post="viruses still threaten humans and animals all over the"/>
  <result pre="have played a significant role in delineating the pathogenesis of" exact="influenza" post="and in the development of vaccines and therapeutics against"/>
  <result pre="adapted strains of influenza. DBA/2j is highly susceptible to non-adapted" exact="influenza" post="strains [72,73,74]. The most common symptoms exhibited by the"/>
  <result pre="However, depending on the dose and the strains of the" exact="influenza" post="virus used, the infection might be lethal. The most"/>
  <result pre="be lethal. The most commonly used mouse adapted strains of" exact="influenza" post="include H1N1 influenza A/Puerto Rico/8/34 (PR8) or H1N1 influenza"/>
  <result pre="most commonly used mouse adapted strains of influenza include H1N1" exact="influenza" post="A/Puerto Rico/8/34 (PR8) or H1N1 influenza A/WSN/1933 (WSN). However,"/>
  <result pre="of influenza include H1N1 influenza A/Puerto Rico/8/34 (PR8) or H1N1" exact="influenza" post="A/WSN/1933 (WSN). However, certain strains, such as the 1918"/>
  <result pre="(WSN). However, certain strains, such as the 1918 H1N1 pandemic" exact="influenza" post="A and the 2009 H1N1 pandemic influenza A, do"/>
  <result pre="1918 H1N1 pandemic influenza A and the 2009 H1N1 pandemic" exact="influenza" post="A, do not require adaptation to infect mice [72,73]."/>
  <result pre="[72,73]. The lack of suitable small-animal models for studies of" exact="influenza" post="pathogenesis and for the development of vaccines and antivirals"/>
  <result pre="widely used in understanding the two most important aspects of" exact="influenza" post="virus, namely: (i) how the early inflammatory response to"/>
  <result pre="influenza virus, namely: (i) how the early inflammatory response to" exact="influenza" post="virus leads to the progression of lung diseases; and"/>
  <result pre="and parental strains differ in virulence. IL-1R1−/− mice infected with" exact="influenza" post="virus were used to demonstrate the role of IL-1α"/>
  <result pre="on IL-18−/− mice revealed the importance of IL-18 in restricting" exact="influenza" post="virus replication in lungs by augmenting the NK cell"/>
  <result pre="role in innate immunity and in moderating lung pathology in" exact="influenza" post="pneumonia [77]. Mice models knocked out for multiple genes"/>
  <result pre="in innate immunity and in moderating lung pathology in influenza" exact="pneumonia" post="[77]. Mice models knocked out for multiple genes can"/>
  <result pre="for studying the combined effects of different molecules on the" exact="influenza" post="pathogenesis. TKO mice (Table 1) deficient in the three"/>
  <result pre="contribution of the TNF and IL-1 inflammatory response to H5N1" exact="influenza" post="A infection. Triple mutant C57BL/6J x 129S background mice"/>
  <result pre="mice (TNF-R KO, C57BL/6J x 129Sv-Tnfrsf1atm1Imx Tnfrsf1btm1Imx/J)] infected with H5N1" exact="influenza" post="A were observed to have longer survival, less morbidity,"/>
  <result pre="that TNF and IL-1 contribute to the pathogenesis of H5N1" exact="influenza" post="A virus [78]. The anti inflammatory role of fatty"/>
  <result pre="role of fatty acid binding protein 5 (FABP5) in H1N1" exact="influenza" post="A virus infection has been demonstrated using FABP5−/− mice."/>
  <result pre="using FABP5−/− mice. Infection of C57BL/6J background mice with H1N1" exact="influenza" post="A virus from which the FABP5 (FABP5−/−) gene had"/>
  <result pre="due to genetic mutations and reassortments. A reassortant seasonal H3N2" exact="influenza" post="A virus containing the PA gene of highly pathogenic"/>
  <result pre="influenza A virus containing the PA gene of highly pathogenic" exact="avian influenza" post="H5N1 influenza A caused severe pneumonia in Casp 1−/−"/>
  <result pre="A virus containing the PA gene of highly pathogenic avian" exact="influenza" post="H5N1 influenza A caused severe pneumonia in Casp 1−/−"/>
  <result pre="containing the PA gene of highly pathogenic avian influenza H5N1" exact="influenza" post="A caused severe pneumonia in Casp 1−/− mice [80]."/>
  <result pre="of highly pathogenic avian influenza H5N1 influenza A caused severe" exact="pneumonia" post="in Casp 1−/− mice [80]. Knockout mice models have"/>
  <result pre="differences in the pathogenicity between reassortment and parental strains of" exact="influenza" post="virus differences that may not be easily observed in"/>
  <result pre="Models of Influenza A Highly pathogenic avian H5 and H7" exact="influenza" post="A viruses continue to cross the species barrier and"/>
  <result pre="in providing an effective innate immune response to control the" exact="influenza" post="virus [83]. Tg mice expressing the entire human MX"/>
  <result pre="(Table 2) exhibit a higher resistance to H5 and H7" exact="influenza" post="A viruses, but are susceptible to H1N1 and H3N2"/>
  <result pre="influenza A viruses, but are susceptible to H1N1 and H3N2" exact="influenza" post="A viruses. Moreover, it was also shown that engineered"/>
  <result pre="viruses. Moreover, it was also shown that engineered avian H7N7" exact="influenza" post="virus with signature mutations found in human viruses was"/>
  <result pre="of Tg mice, researchers can implement new strategies against the" exact="influenza" post="virus. Wang et al. [85] came up with a"/>
  <result pre="RNA (ShRNA) to disrupt the activity of hemagglutinin (HA) of" exact="influenza" post="A virus, thereby inhibiting the virus. They developed a"/>
  <result pre="that specifically targets the conserved sequence of the HA of" exact="influenza" post="A virus. The Tg mice displayed a constant ability"/>
  <result pre="virus. The Tg mice displayed a constant ability to reduce" exact="influenza" post="A virus infection and replication, suggesting the utility of"/>
  <result pre="the utility of an shRNA-based approach to prevent and control" exact="influenza" post="virus infections in animals [85]. Tg mice expressing the"/>
  <result pre="vaccine and to a modified vaccinia Ankara vectored vaccine expressing" exact="influenza" post="virus epitopes. The studies reported that CD8+ T cells"/>
  <result pre="vaccinated HLA-DR3 expressing mice were challenged with pandemic 2009 H1N1" exact="influenza" post="A [88]. Therefore, Tg mice expressing HLA class I"/>
  <result pre="evaluating the CD8+ and CD4+ T cell responses to different" exact="influenza" post="A vaccine candidates. 3.3. Humanized Mouse Models of Influenza"/>
  <result pre="development, the preclinical analysis of the human immune response against" exact="influenza" post="vaccines, and the evaluation of vaccine cytotoxicity. Direct manipulation"/>
  <result pre="strategy, which will help the individuals to protect themselves against" exact="influenza" post="virus [89]. An advanced strategy of augmenting the innate"/>
  <result pre="strategy of augmenting the innate and adaptive immune response to" exact="infectious disease" post="is to expand the γδ-T cells using phosphoantigens [90,91,92]."/>
  <result pre="huPBMC sreconstituted immunodeficient Rag2−/−γc−/− mice (Table 3) infected with H1N1" exact="influenza" post="A and H5N1 influneza A, phosphoantigen selectively activated and"/>
  <result pre="responses with virus-neutralizing activity are considered the best vaccines against" exact="influenza" post="virus infection. Due to the sequence variations in the"/>
  <result pre="the envelope antigens HA and neuraminidase (NA), multiple subtypes of" exact="influenza" post="A virus have evolved and complicated the effective vaccine"/>
  <result pre="a result, for adults who usually have exposure to seasonal" exact="influenza" post="viruses, an annual single dose of the vaccine, boosting"/>
  <result pre="vaccine, boosting the humoral immune response, is sufficient. For emerging" exact="influenza" post="viruses, a single dose of a vaccine is sufficient"/>
  <result pre="to develop cross-reactive human anti-influenza monoclonal antibodies (hu-mAb) to study" exact="influenza" post="infection and investigate the efficacy of anti-influenza antibody-based therapeutics"/>
  <result pre="targeted the HA protein of H1N1 was able to clear" exact="influenza" post="infection in DRAGA mice [97]. The efficacy of vaccines"/>
  <result pre="establishing a humanized mouse model to demonstrate the evaluation of" exact="influenza" post="vaccine safety based on the expression of bio marker"/>
  <result pre="belongs to the family Flaviviridae and is closely related to" exact="hepatitis" post="C, West Nile, Zika, [100] and Japanese encephalitis viruses."/>
  <result pre="related to hepatitis C, West Nile, Zika, [100] and Japanese" exact="encephalitis" post="viruses. These family virus outbreaks are being reported throughout"/>
  <result pre="encephalitis-like symptoms and neurotoxicity. Moreover, anti TNF-α antibodies reduced dengue" exact="encephalitis" post="and mortality, suggesting anti TNF-α-based therapeutics for dengue encephalitis"/>
  <result pre="dengue encephalitis and mortality, suggesting anti TNF-α-based therapeutics for dengue" exact="encephalitis" post="[115]. Since mice lacking the IFN-α/β receptor are susceptible"/>
  <result pre="the clinical symptoms of dengue with a fever, rash, and" exact="thrombocytopenia" post="[118]. Antibody responses mimicking primary dengue infection have been"/>
  <result pre="model for research purposes. An ideal animal model for human" exact="viral disease" post="should closely recapitulate the spectrum of clinical symptoms and"/>
  <result pre="Such conditional KO and Tg mice are available for studying" exact="cancer" post="and need to be developed for studying viral diseases."/>
  <result pre="2018) 2.NairH.BrooksW.A.KatzM.RocaA.BerkleyJ.A.MadhiS.A.SimmermanJ.M.GordonA.SatoM.HowieS.et al.Global burden of respiratory infections due to seasonal" exact="influenza" post="in young children: A systematic review and meta-analysisLancet20113781917193010.1016/S0140-6736(11)61051-922078723 3.BarrilaJ.RadtkeA.L.CrabbéA.SarkerS.F.Herbst-KralovetzM.M.OttC.M.NickersonC.A.Organotypic"/>
  <result pre="interactionsNat. Rev. Microbiol.2010879180110.1038/nrmicro242320948552 4.BotA.CasaresS.BotS.Von BoehmerH.BonaC.Cellular mechanisms involved in protection against" exact="influenza" post="virus infection in transgenic mice expressing a TCR receptor"/>
  <result pre="the experts�? 2015 workshop summaryAIDS Res. Hum. Retrovir.20163210911910.1089/aid.2015.025826670361 55.HorwitzJ.A.Halper-StrombergA.MouquetH.GitlinA.D.TretiakovaA.EisenreichT.R.MalbecM.GravemannS.BillerbeckE.DornerM.et al.HIV-1" exact="suppression" post="and durable control by combining single broadly neutralizing antibodies"/>
  <result pre="COPDInt. J. Chron Obstruct. Pulmon. Dis.200725510.2147/copd.2007.2.1.5518044066 66.KimM.H.SongW.J.YangM.S.LeeS.H.KwonJ.W.KimS.H.KangH.R.ParkH.W.ChoY.J.ChoS.H.et al.Clinical course of" exact="asthma" post="patients with H1N1 influenza infection and oseltamivirMinerva Med.201810971428880061 67.BarnesM.HeywoodA.E.MahimboA.RahmanB.NewallA.T.MacintyreC.R.Acute"/>
  <result pre="Pulmon. Dis.200725510.2147/copd.2007.2.1.5518044066 66.KimM.H.SongW.J.YangM.S.LeeS.H.KwonJ.W.KimS.H.KangH.R.ParkH.W.ChoY.J.ChoS.H.et al.Clinical course of asthma patients with H1N1" exact="influenza" post="infection and oseltamivirMinerva Med.201810971428880061 67.BarnesM.HeywoodA.E.MahimboA.RahmanB.NewallA.T.MacintyreC.R.Acute myocardial infarction and influenza:"/>
  <result pre="and influenza: A meta-analysis of case–control studiesHeart20151011738174710.1136/heartjnl-2015-30769126310262 68.Stanwell-SmithR.ParkerA.M.ChakravertyP.SoltanpoorN.SimpsonC.N.Possible association of" exact="influenza" post="A with fetal loss: Investigation of a cluster of"/>
  <result pre="69.PaleseP.Influenza: Old and new threatsNat. Med.200410S8210.1038/nm114115577936 70.HorimotoT.KawaokaY.Pandemic threat posed by" exact="avian influenza" post="A virusesClin. Microbiol. Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the"/>
  <result pre="Old and new threatsNat. Med.200410S8210.1038/nm114115577936 70.HorimotoT.KawaokaY.Pandemic threat posed by avian" exact="influenza" post="A virusesClin. Microbiol. Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the"/>
  <result pre="Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the pandemic 2009 A (H1N1)" exact="influenza" post="virus in A ferret modelPLoS Pathog.20139100335410.1371/journal.ppat.1003354 72.MargineI.KrammerF.Animal models for"/>
  <result pre="influenza virus in A ferret modelPLoS Pathog.20139100335410.1371/journal.ppat.1003354 72.MargineI.KrammerF.Animal models for" exact="influenza" post="viruses: Implications for universal vaccine developmentPathogens2014384587410.3390/pathogens304084525436508 73.BlazejewskaP.KoscinskiL.ViegasN.AnhlanD.LudwigS.SchughartK.Pathogenicity of different"/>
  <result pre="viruses: Implications for universal vaccine developmentPathogens2014384587410.3390/pathogens304084525436508 73.BlazejewskaP.KoscinskiL.ViegasN.AnhlanD.LudwigS.SchughartK.Pathogenicity of different PR8" exact="influenza" post="A virus variants in mice is determined by both"/>
  <result pre="host factorsVirology2011412364510.1016/j.virol.2010.12.04721256531 74.SrivastavaB.BłażejewskaP.HeßmannM.BruderD.GeffersR.MauelS.GruberA.D.SchughartK.Host genetic background strongly influences the response to" exact="influenza" post="a virus infectionsPLoS ONE20094e485710.1371/journal.pone.000485719293935 75.SchmitzN.KurrerM.BachmannM.F.KopfM.Interleukin-1 is responsible for acute"/>
  <result pre="responsible for acute lung immunopathology but increases survival of respiratory" exact="influenza" post="virus infectionJ. Virol.2005796441644810.1128/JVI.79.10.6441-6448.200515858027 76.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system"/>
  <result pre="virus infectionJ. Virol.2005796441644810.1128/JVI.79.10.6441-6448.200515858027 76.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system against" exact="influenza" post="virus infection by augmenting natural killer cell-mediated cytotoxicityJ. Gen."/>
  <result pre="77.ThomasP.G.DashP.AldridgeJ.R.Jr.EllebedyA.H.ReynoldsC.FunkA.J.MartinW.J.LamkanfiM.WebbyR.J.BoydK.L.et al.NLRP3 (NALP3/CIAS1/Cryopyrin) mediates key innate and healing responses to" exact="influenza" post="A virus via the regulation of caspase-1Immunity.20093056610.1016/j.immuni.2009.02.00619362023 78.PerroneL.A.SzretterK.J.KatzJ.M.MizgerdJ.P.TumpeyT.M.Mice lacking"/>
  <result pre="H5N1 virusJ. Infect. Dis.20102021161117010.1086/65636520815704 79.GallyF.KosmiderB.WeaverM.R.PateK.M.HartshornK.L.Oberley-DeeganR.E.FABP5 deficiency enhances susceptibility to H1N1" exact="influenza" post="A virus-induced lung inflammationAm. J. Physiol. Lung Cell. Mol."/>
  <result pre="Cell. Mol. Physiol.2013305647210.1152/ajplung.00276.2012 80.HuangC.H.ChenC.J.YenC.T.YuC.P.HuangP.N.KuoR.L.LinS.J.ChangC.K.ShihS.R.Caspase-1 deficient mice are more susceptible to" exact="influenza" post="A virus infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic"/>
  <result pre="virus infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of" exact="avian influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of influenza A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763"/>
  <result pre="infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of avian" exact="influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of influenza A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763"/>
  <result pre="potential of avian influenza A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of" exact="influenza" post="A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763 83.HallerO.StaeheliP.SchwemmleM.KochsG.Mx GTPases: Dynamin-like antiviral machines of innate"/>
  <result pre="innate immunityTrends Microbiol.20152315416310.1016/j.tim.2014.12.00325572883 84.DeegC.M.HassanE.MutzP.RheinemannL.GotzV.MagarL.SchillingM.KallfassC.NurnbergerC.SoubiesS.et al.In vivo evasion of MxA by" exact="avian influenza" post="viruses requires human signature in the viral nucleoproteinJ. Exp."/>
  <result pre="immunityTrends Microbiol.20152315416310.1016/j.tim.2014.12.00325572883 84.DeegC.M.HassanE.MutzP.RheinemannL.GotzV.MagarL.SchillingM.KallfassC.NurnbergerC.SoubiesS.et al.In vivo evasion of MxA by avian" exact="influenza" post="viruses requires human signature in the viral nucleoproteinJ. Exp."/>
  <result pre="signature in the viral nucleoproteinJ. Exp. Med.20172141239124810.1084/jem.2016103328396461 85.WangS.ChenC.YangZ.ChiX.ZhangJ.ChenJ.L.Targeted disruption of" exact="influenza" post="A virus hemagglutinin in genetically modified mice reduces viral"/>
  <result pre="HLA-A2. 1 transgenic miceVirol. J.2016135610.1186/s12985-016-0513-727036323 87.Di MarioG.SciaraffiaE.FacchiniM.GubinelliF.SopranaE.PanigadaM.BernasconiV.GarulliB.SiccardiA.DonatelliI.et al.Protective immunity against" exact="influenza" post="in HLA-A2 transgenic mice by modified vaccinia virus Ankara"/>
  <result pre="al.Protective immunity against influenza in HLA-A2 transgenic mice by modified" exact="vaccinia virus" post="Ankara vectored vaccines containing internal influenza proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473"/>
  <result pre="mice by modified vaccinia virus Ankara vectored vaccines containing internal" exact="influenza" post="proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473 88.MoiseL.TassoneR.LatimerH.TerryF.LevitzL.HaranJ.P.RossT.M.BoyleC.MartinW.D.De GrootA.S.Immunization with cross-conserved H1N1 influenza"/>
  <result pre="internal influenza proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473 88.MoiseL.TassoneR.LatimerH.TerryF.LevitzL.HaranJ.P.RossT.M.BoyleC.MartinW.D.De GrootA.S.Immunization with cross-conserved H1N1" exact="influenza" post="CD4+ T-cell epitopes lowers viral burden in HLA DR3"/>
  <result pre="DR3 transgenic miceHum. Vaccin Immunother.201392060206810.4161/hv.2651124045788 89.PeirisJ.M.PoonL.L.GuanY.Emergence of a novel swine-origin" exact="influenza" post="A virus (S-OIV) H1N1 virus in humansJ. Clin. Virol.20094516917310.1016/j.jcv.2009.06.00619540800"/>
  <result pre="94.RichardsK.A.TophamD.ChavesF.A.SantA.J.Cutting edge: CD4 T cells generated from encounter with seasonal" exact="influenza" post="viruses and vaccines have broad protein specificity and can"/>
  <result pre="live pandemic H1N1 virusJ. Immunol.2010100139510.4049/jimmunol.100139520889549 95.MulliganM.J.BernsteinD.I.WinokurP.RuppR.AndersonE.RouphaelN.DickeyM.StapletonJ.T.EdupugantiS.SpearmanP.et al.Serological responses to an" exact="avian influenza" post="A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant:"/>
  <result pre="pandemic H1N1 virusJ. Immunol.2010100139510.4049/jimmunol.100139520889549 95.MulliganM.J.BernsteinD.I.WinokurP.RuppR.AndersonE.RouphaelN.DickeyM.StapletonJ.T.EdupugantiS.SpearmanP.et al.Serological responses to an avian" exact="influenza" post="A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant:"/>
  <result pre="preclinical humanized mouse model to evaluate acute toxicity of an" exact="influenza" post="vaccineOncotarget201892575110.18632/oncotarget.2539929899819 100.AlagarasuK.BachalR.V.BhagatA.B.ShahP.S.DayarajC.Elevated levels of vitamin D and deficiency of"/>
  <result pre="multiplex real-time RT-PCR assay for simultaneous detection of dengue and" exact="chikungunya" post="virusesArch. Virol.201516032332710.1007/s00705-014-2217-x25233940 102.ZompiS.HarrisE.Animal models of dengue virus infectionViruses20124628210.3390/v401006222355452 103.FalzaranoD.BenteD.A.Animal"/>
  <result pre="antiviral drug testingJ. Virol.2014882205221810.1128/JVI.03085-1324335303 127.MotaJ.Rico-HesseR.Humanized mice show clinical signs of" exact="dengue fever" post="according to infecting virus genotypeJ. Virol.2009838638864510.1128/JVI.00581-0919535452 128.CoxJ.MotaJ.Sukupolvi-PettyS.DiamondM.S.Rico-HesseR.Mosquito bite delivery"/>
  <result pre="human diseaseTransgenic Res.20122132734910.1007/s11248-011-9537-321800101 134.Ostrand-RosenbergS.Animal models of tumor immunity, immunotherapy and" exact="cancer" post="vaccinesCurr. Opin. Immunol.20041614315010.1016/j.coi.2004.01.00315023405 135.BouabeH.OkkenhaugK.Gene Targeting in Mice: A ReviewMethods"/>
  <result pre="and caspase deficient. Innate immunity and moderating lung pathology in" exact="influenza" post="pneumonia [77] C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory"/>
  <result pre="caspase deficient. Innate immunity and moderating lung pathology in influenza" exact="pneumonia" post="[77] C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory response"/>
  <result pre="C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory response against H1N1" exact="influenza" post="A [79] 3. Dengue 129Sv(ev) (AG129 KO) Type I&amp;amp;"/>
  <result pre="a 3.1-kb deletion in the Gag and Pol regions HIV-associated" exact="nephropathy" post="[42] 2. Influenza B6.SJL Tg Mice MX1, MX2, FAM3B"/>
  <result pre="Mice MX1, MX2, FAM3B and TMPRSS2 genes Zoonotic transmission of" exact="influenza" post="A viruses [83,84] BALB/c. Tg Influenza A HA Sh-RNAcodes"/>
  <result pre="of heamagglutinin Prevention and control of a viral zoonosis of" exact="influenza" post="[84,85] 3. Dengue C57BL/6J Tg HLA-A*02:01 and B10. Tg."/>
 </snippets>
</snippetsTree>
